OxCan (Oxford Cancer Analytics)
Oxford, GB · 8 known investors
Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making. Its focus is on lung disease, beginning with Chronic Obstructive Pulmonary Disease (COPD) and extending to conditions such as lung cancer.
Founders & leadership
Investors · 8
Eka Ventures✓ verifiedLondon · $635K – $3.8M
Cross-Border Impact Ventures✓ verifiedToronto · $2M – $10M
Meridian Health Ventures✓ verifiedLondon
UK Innovation & Science Seed Fund✓ verifiedLondon · $127K – $635K
Civilization Ventures Management, LlcTiburon · $1M – $10M
DigitalDx VenturesMenlo Park
OnstageLondon
Oxford Technology ManagementOxford · $200K – $400K
Frequently asked questions
- What does OxCan (Oxford Cancer Analytics) do?
- Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making. Its focus is on lung disease, beginning with Chronic Obstructive Pulmonary Disease (COPD) and extending to conditions such as lung cancer.
- Who founded OxCan (Oxford Cancer Analytics)?
- OxCan (Oxford Cancer Analytics) was founded by Andreas Halner.
- Who are OxCan (Oxford Cancer Analytics)'s investors?
- OxCan (Oxford Cancer Analytics)'s investors include Eka Ventures, Cross-Border Impact Ventures, Meridian Health Ventures, UK Innovation & Science Seed Fund, Civilization Ventures Management, Llc, DigitalDx Ventures, Onstage, Oxford Technology Management.
- Where is OxCan (Oxford Cancer Analytics) headquartered?
- OxCan (Oxford Cancer Analytics) is headquartered in Oxford, GB.